Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03198390 · ClinicalTrials.gov registry record
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
A clinical trial, sponsored by University of Arizona.
- Terminated
- Registry status
- 100
- Enrollment target
NCT03198390: Clinical Trial study, sponsored by University of Arizona.
NCT03198390 is a clinical trial that was terminated before completion, run by University of Arizona. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03198390 was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Investigators will sample the skin and blood of patients with chronic skin conditions (including but not limited to atopic dermatitis (AD), contact dermatitis, hidradenitis suppurativa (HS), and psoriasis) to study the expression of anti-oxidative enzymes, skin barrier proteins and inflammatory molecules. In patients with atopic dermatitis, investigators will also measure skin barrier function using noninvasive devices. These results will be correlated with the disease severity in atopic dermatitis patients.
Primary Outcome
Transepidermal water loss (TEWL) status will be measured using hand-held, noninvasive, skin barrier measuring device (Tewameter).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-08-04 |
| Est. Completion | 2020-05-31 |
Why NCT03198390 stopped before completion
NCT03198390 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03198390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03198390 about?
NCT03198390 is a clinical study titled "Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions". Investigators will sample the skin and blood of patients with chronic skin conditions (including but not limited to atopic dermatitis (AD), contact dermatitis, hidradenitis suppurativa (HS), and psoriasis) to study the expression of anti-oxidative enzymes, skin barrier proteins and inflammatory mole...
What is the current status of trial NCT03198390?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2017-08-04. Estimated completion is 2020-05-31.
Who is sponsoring clinical trial NCT03198390?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI